Expertise in
8
conditions

Dr. Douglas W. Scharre

Neurology
Ohio State Outpatient Care New Albany
6100 N Hamilton Rd, 
Westerville, OH 
Accepting New Patients
Offers Telehealth
Expertise in
8
conditions
Ohio State Outpatient Care New Albany
6100 N Hamilton Rd, 
Westerville, OH 

Overview

Douglas Scharre is a Neurologist practicing medicine in Westerville, Ohio.

Dr. Scharre is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Lewy Body Dementia (LBD), Dementia, Neuronal Intranuclear Inclusion Disease (NIID), and Alzheimer's Disease.

He is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 20 clinical trials. Dr. Scharre is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in OH

Hospital Affiliations

Ohio State University State Health System

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Ohio State Outpatient Care New Albany
6100 N Hamilton Rd, Westerville, OH 43081
Other Locations
Ohio State Martha Morehouse Outpatient Care
2050 Kenny Rd, Columbus, OH 43221

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Enrollment Status: Completed
Publish Date: March 12, 2026
Intervention Type: Drug
Study Drug: CT1812
Study Phase: Phase 2
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Enrollment Status: Completed
Publish Date: March 11, 2026
Long-Term Nicotine Treatment of Mild Cognitive Impairment
Long-Term Nicotine Treatment of Mild Cognitive Impairment
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Nicotine Transdermal Patch
Study Phase: Phase 2
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 22, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Drug
Study Drug: CT1812
Study Phase: Phase 2
Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Enrollment Status: Completed
Publish Date: June 13, 2025
Intervention Type: Drug, Other
Study Drug: Donanemab
Study Phase: Phase 2
Escitalopram for Agitation in Alzheimer's Disease
Escitalopram for Agitation in Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drug: Escitalopram
Study Phase: Phase 3
Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
Trial Ready Cohort for the Prevention of Alzheimer's Dementia (TRC-PAD)
Enrollment Status: Completed
Publish Date: June 27, 2024
View 9 Less Clinical Trials

45 Total Publications

Flexible Multimodal Neuroimaging Fusion for Alzheimer's Disease Progression Prediction.
Flexible Multimodal Neuroimaging Fusion for Alzheimer's Disease Progression Prediction.
Journal: Applications of medical artificial intelligence. AMAI (Workshop) (4th : 2024 : Taejon-si, Korea)
Published: April 09, 2026
Similar Doctors
Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required

Nationwide Children's Hospital

700 Childrens Dr, 
Columbus, OH 
 (11.3 miles away)
614-722-2203
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dr. Jerry Mendell, MD is a Neurology Specialist in Columbus, OH and has over 56 years of experience in the medical field. He graduated from University of Texas Southwestern Medical School in 1966. Dr. Mendell is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy, and Spinal Muscular Atrophy (SMA). Dr. Mendell is currently accepting new patients.

Expertise in
34
conditions
Expertise in
34
conditions
Referral may be required

Ohio State University Hospital-Pavilion

300 W 10th Ave, 
Columbus, OH 
 (10.7 miles away)
614-366-7744
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pierre Giglio is a Neurologist practicing medicine in Columbus, Ohio. Dr. Giglio is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Giglio is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral required
Before you request

Nationwide Children's Hospital

700 Childrens Dr, 
Columbus, OH 
 (11.3 miles away)
614-722-4625
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anup Patel is a Neurologist practicing medicine in Columbus, Ohio. Dr. Patel is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Epilepsy, Lennox-Gastaut Syndrome (LGS), West Syndrome, and Seizures. Dr. Patel is currently accepting new patients.

Frequently Asked Questions about Dr. Douglas W. Scharre

How do I make an appointment with Dr. Douglas W. Scharre?

You can book an appointment with Dr. Douglas W. Scharre by calling their office at 614-814-8100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Douglas W. Scharre a top-rated expert for Lewy Body Dementia (LBD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Douglas W. Scharre is classified as an Distinguished expert for Lewy Body Dementia (LBD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Douglas W. Scharre specialize in?

While Dr. Douglas W. Scharre is a Neurology, they have specific expertise in Lewy Body Dementia (LBD), Dementia, and Neuronal Intranuclear Inclusion Disease (NIID). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Douglas W. Scharre participate in research or clinical trials?

Yes. Dr. Douglas W. Scharre has published 45 articles and abstracts on conditions like Lewy Body Dementia (LBD). You can view a list of Dr. Douglas W. Scharre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Douglas W. Scharre accept my insurance?

Dr. Douglas W. Scharre accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-814-8100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Scharre's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile